Supplementary Data from Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose Study
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Figures S1-S2.
Authors: Denis C. Talbot, Malcolm Ranson, Joanna Davies, Michael Lahn, Sophie Callies, Valérie André, Sunil Kadam, Michael Burgess, Christopher Slapak, Anna L Olsen, Peter J. McHugh, Johann S. de Bono, Julian Matthews, Azeem Saleem, Patricia Price
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4361880561
